In this issue:
- Diagnostic tools used for melanoma in Australia
- Delayed immune-related adverse events with anti-PD-1 in melanoma
- Naevus-associated vs. de novo melanoma: thickness and body site differences
- Local therapy for solitary melanoma progression on ICIs
- Incomplete surgical excision of keratinocyte skin cancers
- Pembrolizumab + ipilimumab after anti-PD-1/L1 failure in melanoma
- BCC and dermal naevi of the face: localisation and dermatoscopic features
- Cemiplimab in locally advanced BCC after hedgehog inhibitor therapy
- MoleMap: real-world outcomes of melanoma surveillance
- Real-world combination ICI and targeted therapies for melanoma brain metastases
Please login below to download this issue (PDF)